NO171886C - PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION IN THE FORM OF AN Aqueous DISPERSION CONTAINING LIPOSOMES CONSISTING OF PHOSPHOLIPIDE COMPONENTS - Google Patents

PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION IN THE FORM OF AN Aqueous DISPERSION CONTAINING LIPOSOMES CONSISTING OF PHOSPHOLIPIDE COMPONENTS

Info

Publication number
NO171886C
NO171886C NO863315A NO863315A NO171886C NO 171886 C NO171886 C NO 171886C NO 863315 A NO863315 A NO 863315A NO 863315 A NO863315 A NO 863315A NO 171886 C NO171886 C NO 171886C
Authority
NO
Norway
Prior art keywords
preparation
appropriate
pharmaceutically acceptable
phospholipide
procedure
Prior art date
Application number
NO863315A
Other languages
Norwegian (no)
Other versions
NO171886B (en
NO863315D0 (en
NO863315L (en
Inventor
Alan J Schroit
Rajiv Nayar
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO863315D0 publication Critical patent/NO863315D0/en
Publication of NO863315L publication Critical patent/NO863315L/en
Publication of NO171886B publication Critical patent/NO171886B/en
Publication of NO171886C publication Critical patent/NO171886C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The compositions consist of a) a phospholipid of the formula <IMAGE> in which m is two or three, R1 and R2 are, independently of one another, alkyl, alkenyl or acyl each with 10 to 20 C atoms, and X is a direct bond, C1-C4-alkylene, C2-C4-alkenylene or C1-C4-alkylene or C2-C4-alkenylene substituted by hydroxyl, or a pharmaceutically acceptable salt thereof, b) a phospholipid of the formula <IMAGE> in which R3 and R4 are the acyl group of a saturated or unsaturated carboxylic acid with 10 to 20 C atoms and 1 to 2 double bonds, c) a compound or a mixture of compounds with pharmacological properties and, where appropriate, d) a lipid from the group comprising phosphatidylcholines, phosphatidylserine, phosphatidylinositol, phosphatidylglycerol, cardiolipin and cholesterol and, where appropriate, a pharmaceutically acceptable carrier solution which is buffered to pH 7.0 to 7.8 and, where appropriate, pharmaceutically acceptable auxiliaries. The compositions can be used in the form of liposomes as administration systems, for example for cancer chemotherapy.
NO863315A 1985-08-19 1986-08-18 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION IN THE FORM OF AN Aqueous DISPERSION CONTAINING LIPOSOMES CONSISTING OF PHOSPHOLIPIDE COMPONENTS NO171886C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76662585A 1985-08-19 1985-08-19

Publications (4)

Publication Number Publication Date
NO863315D0 NO863315D0 (en) 1986-08-18
NO863315L NO863315L (en) 1987-02-20
NO171886B NO171886B (en) 1993-02-08
NO171886C true NO171886C (en) 1993-05-19

Family

ID=25077017

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863315A NO171886C (en) 1985-08-19 1986-08-18 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION IN THE FORM OF AN Aqueous DISPERSION CONTAINING LIPOSOMES CONSISTING OF PHOSPHOLIPIDE COMPONENTS

Country Status (18)

Country Link
EP (1) EP0213523B1 (en)
JP (1) JPS6296431A (en)
KR (1) KR870001838A (en)
AT (1) ATE59002T1 (en)
AU (1) AU591162B2 (en)
CA (1) CA1273575A (en)
DD (1) DD248736A5 (en)
DE (1) DE3676133D1 (en)
DK (1) DK165314C (en)
ES (1) ES2001099A6 (en)
FI (1) FI863311A (en)
GR (1) GR862144B (en)
HU (1) HU206045B (en)
NO (1) NO171886C (en)
NZ (1) NZ217239A (en)
PH (1) PH26160A (en)
PT (1) PT83204B (en)
ZA (1) ZA866200B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT85537B (en) * 1986-08-18 1990-06-29 Univ Texas METHOD FOR PREPARING A PHARMACEUTICAL ADMINISTRATION SYSTEM CONTAINING PEPTIDES PRESENTING CHIMIOTAXIA
DK86988A (en) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd LIPOSOM PREPARATION AND APPLICATION THEREOF
AU7496991A (en) * 1990-03-20 1991-10-21 Otsuka Pharmaceutical Co., Ltd. Liposome preparation
EP1118326A3 (en) * 1993-05-21 2002-07-31 The Liposome Company, Inc. Reduction of liposome-induced adverse physiological reactions
KR100381449B1 (en) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 Application of ether lipid liposomal enzymes to pharmaceuticals
US7306784B2 (en) 1998-06-20 2007-12-11 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6589503B1 (en) 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7803351B2 (en) 2004-08-20 2010-09-28 Washington University Blood brain barrier permeation peptides
JP2006248978A (en) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd New liposome preparation
EP3676296A1 (en) 2017-08-30 2020-07-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218027A1 (en) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln PHOSPHOLIPID SOLUTIONS

Also Published As

Publication number Publication date
FI863311A0 (en) 1986-08-15
KR870001838A (en) 1987-03-28
DK392786D0 (en) 1986-08-18
AU591162B2 (en) 1989-11-30
DK165314C (en) 1993-03-29
FI863311A (en) 1987-02-20
NO171886B (en) 1993-02-08
AU6155686A (en) 1987-02-26
DD248736A5 (en) 1987-08-19
PT83204B (en) 1989-03-30
PT83204A (en) 1986-09-01
EP0213523A2 (en) 1987-03-11
NZ217239A (en) 1989-09-27
NO863315D0 (en) 1986-08-18
EP0213523A3 (en) 1987-10-14
ES2001099A6 (en) 1988-04-16
HU206045B (en) 1992-08-28
DE3676133D1 (en) 1991-01-24
CA1273575A (en) 1990-09-04
JPS6296431A (en) 1987-05-02
DK392786A (en) 1987-02-20
EP0213523B1 (en) 1990-12-12
NO863315L (en) 1987-02-20
DK165314B (en) 1992-11-09
ATE59002T1 (en) 1990-12-15
ZA866200B (en) 1987-03-25
PH26160A (en) 1992-03-18
HUT41634A (en) 1987-05-28
GR862144B (en) 1986-12-23

Similar Documents

Publication Publication Date Title
US4362737A (en) Transdermal carrier materials
KR890011601A (en) (Cycloalkylamino) methylenebis (phosphonic acid) and pharmaceuticals containing it as active ingredient
WO1990004918A3 (en) Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
NL300396I1 (en) Novel derivatives with naphthalene structures, process for their preparation and the pharmaceutical preparations containing them
NO171886C (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION IN THE FORM OF AN Aqueous DISPERSION CONTAINING LIPOSOMES CONSISTING OF PHOSPHOLIPIDE COMPONENTS
ES2035824T3 (en) PROCEDURE FOR PREPARING PROFARMAC COMPOUNDS AND PREPARATIONS CONTAINING THEM.
NO178923C (en) Analogous Process for Preparation of Therapeutically Active 24-Homo Vitamin D Derivatives
FI834702A (en) NYA NITROALIFATISKA FOERENINGAR, DERAS FRAMSTAELLNINGSFOERFARANDE OCH ANVAENDNING.
IL87254A (en) Stable oxapenem- 3-carboxylic acids, their preparation and pharmaceutical compositions containing them
YU33592A (en) CRYSTAL ACID ADDITIVE SALTS OF DIASTEREOMEROUS PURE 1- (2,2-DIMETHYLPROPIONYLOC-SI) -ETHYLTER 3-CEFEM-4-CARBOXYLIC ACIDS
ES8704970A1 (en) Process for the preparation of corticosteroid-21-phosphoric acids and their salts, and the triesters of certicusteroid-21-phosphoric acid.
PT86422A (en) PROCESS FOR THE PREPARATION OF DIBENZO] BE-OXEPINE-ACETIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES8602789A1 (en) Eburnane derivatives.
KR900012934A (en) Pyrido pyrimidine derivatives, pharmaceutical compositions containing them and methods for preparing them
RU94042399A (en) Preparation of clavulanic acid from clavulanic acid salt and amine, clavulanic acid and amine salts
JO1870B1 (en) Novel dialkoxy - pyridinyl-benzimidazole derivatives
IT8149066A0 (en) 7-BETA ACID (ALPHA-SIN-METHOXYMIMS NO-ALPHA-(2-AMMINOTHIAZOL-4-IL)-ACE THAMIDE)-3-(1,2,3-THIAZOL-5-YLTHIO)METHYL)3-CEFEM-4 -CARBOXYLIC AND ITS ALKYL DERIVATIVES OF 1 TO 6 CARBON ATOMS USEFUL AS ANTIBACTERIAL AGENTS AND PROCEDURE FOR THEIR PREPARATION